The EPO maintains that only natural persons can be designated as inventors under European patent law.
Federal Circuit Affirms $95 Million Verdict in E-Cigarette Patent Battle Between Altria and Reynolds
The Altria v. R.J. Reynolds decision clarifies patent damages methodology, specifically in comparable license analysis and apportionment.
Federal Circuit Upholds PTAB Win for Patent to Detect Genetic Disorders
The Federal Circuit upheld the PTAB's ruling that Labcorp did not prove the obviousness of Ravgen's DNA sampling patent.
Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting Invalidation
The Federal Circuit reversed previous invalidity rulings on key pharmaceutical patents, emphasizing the significance of prosecution delays and patent term extensions.
Federal Circuit Affirms Invalidity of Purdue's OxyContin Patents
The Federal Circuit affirmed the invalidity of Purdue Pharma's OxyContin patents due to obviousness, impacting patent law standards.
The ruling highlights the importance of analyzing inherent properties and known problems in patent obviousness evaluations.
CAFC Delivers Win for Meta in Precedential Decision
The CAFC affirmed non-infringement rulings for Facebook, emphasizing the need for authenticated evidence in patent litigation.
DABUS AI Again Denied European Patent
The EPO maintains that only natural persons can be designated as inventors under European patent law.
Federal Circuit Affirms $95 Million Verdict in E-Cigarette Patent Battle Between Altria and Reynolds
The Altria v. R.J. Reynolds decision clarifies patent damages methodology, specifically in comparable license analysis and apportionment.
Federal Circuit Upholds PTAB Win for Patent to Detect Genetic Disorders
The Federal Circuit upheld the PTAB's ruling that Labcorp did not prove the obviousness of Ravgen's DNA sampling patent.
Federal Circuit Emphasizes Role of Filing Dates, Reversing Obviousness-Type Double Patenting Invalidation
The Federal Circuit reversed previous invalidity rulings on key pharmaceutical patents, emphasizing the significance of prosecution delays and patent term extensions.
Federal Circuit Affirms Invalidity of Purdue's OxyContin Patents
The Federal Circuit affirmed the invalidity of Purdue Pharma's OxyContin patents due to obviousness, impacting patent law standards.
The ruling highlights the importance of analyzing inherent properties and known problems in patent obviousness evaluations.
CAFC Delivers Win for Meta in Precedential Decision
The CAFC affirmed non-infringement rulings for Facebook, emphasizing the need for authenticated evidence in patent litigation.
The Year Ahead: Here's What Our Readers Will Have on their Radar for 2025
Legal predictions for 2024 point towards transformative changes in student athlete rights regarding NIL, influenced by ongoing lawsuits and legislative efforts.
The UPC in 2024: Statistics, Trends and Substantive Law
The UPC has effectively resolved over 20 substantive decisions on patent infringement within a year, granting injunctions in all valid and infringed cases.
The Year Ahead: Here's What Our Readers Will Have on their Radar for 2025
Legal predictions for 2024 point towards transformative changes in student athlete rights regarding NIL, influenced by ongoing lawsuits and legislative efforts.
The UPC in 2024: Statistics, Trends and Substantive Law
The UPC has effectively resolved over 20 substantive decisions on patent infringement within a year, granting injunctions in all valid and infringed cases.
The USPTO grant rate has significantly increased since 2010 due to policy changes, but recent trends indicate a possible recalibration under new leadership.
Hundreds of Trademark Applicants Get Erroneous Notices of Abandonment from USPTO
A system error at the USPTO led to incorrect abandonment notices for hundreds of trademark applications, prompting significant client frustration.
Many Paths to Patent Issuance
Navigating USPTO patent prosecution is intricate, sometimes requiring guidance similar to Ariadne's thread.
Howard Lutnick and the Patent System
Howard Lutnick's nomination as Secretary of Commerce could significantly impact patent policy due to his unique experiences in invention and litigation.
What Happened at the USPTO in 2024-and What's to Come
Upcoming USPTO leadership changes will influence patent policies in 2025, particularly with the new Director's potential alignment with previous Big Tech policies.
Some numbers from this week
High allowance rates in different patent categories indicate variability in scrutiny levels within the USPTO.
USPTO Patent Grant Rate and Growing Backlog
The USPTO grant rate has significantly increased since 2010 due to policy changes, but recent trends indicate a possible recalibration under new leadership.
Hundreds of Trademark Applicants Get Erroneous Notices of Abandonment from USPTO
A system error at the USPTO led to incorrect abandonment notices for hundreds of trademark applications, prompting significant client frustration.
Many Paths to Patent Issuance
Navigating USPTO patent prosecution is intricate, sometimes requiring guidance similar to Ariadne's thread.
Howard Lutnick and the Patent System
Howard Lutnick's nomination as Secretary of Commerce could significantly impact patent policy due to his unique experiences in invention and litigation.
What Happened at the USPTO in 2024-and What's to Come
Upcoming USPTO leadership changes will influence patent policies in 2025, particularly with the new Director's potential alignment with previous Big Tech policies.
Some numbers from this week
High allowance rates in different patent categories indicate variability in scrutiny levels within the USPTO.
Intentionally Building and Managing an In-House IP Team
Building an in-house IP team requires a holistic approach that integrates strategy, personnel, and operations for maximum effectiveness.
Delaware Supreme Court Refuses to Enforce Noncompete Against Company Founder Who Joined Competitor
Delaware courts can strike down overbroad restrictive covenants rather than modifying them, affirming enforceability standards in contractual agreements.
The Briefing: Is This Just A Copycat Influencer Case or Something More Problematic?
Can an influencer sue another for having a similar aesthetic?Scott Hervey and Jessica Marlow dive into a Texas case that could reshape creator marketing on this episode of The Briefing.
Understanding IP Matters: Ex-War Photographer Helps Remove the Source Mystery from Images and Content
Provenance of digital content is essential for credibility in an AI-driven world.
The U.S. Supreme Court upheld lower court rulings requiring Zimmer Biomet to continue paying royalties, citing the separation of royalties from patent rights in the agreement.
Institutional Stonewalling: The Federal Circuit's Silent Treatment Through Rule 36
Stonewalling in relationships parallels the Federal Circuit's Rule 36 summary affirmances, stifling meaningful engagement and progress in legal arguments.
The Briefing: Trademark Turbulence - Oakland vs SFO in Trademark Showdown
Oakland's attempt to rename its airport didn't take off.
Expert Witness Ethics and Economics: Unpacking the Federal Circuit's En Banc Review of Damages Testimony in EcoFactor v. Google
Expert witnesses often face ethical dilemmas between objectivity and financial incentives, which can compromise their integrity and the judicial process.
Hear from the Experts: How Patent Litigation Funding is Used to Hedge Risk
Litigation finance supports patent rights and acts as a public good by facilitating financial resources for patent holders.
Economist Will Page Reports Global Value of Music Copyright Exceeded Movie Box Office Receipts in 2023
Global music copyright revenues rose 11% to $45.5 billion in 2023, surpassing cinema's $28.6 billion, aided by pandemic recovery.
The Next USPTO Director: Duffy's Four Factor Test
The next USPTO Director should embrace a broader approach to patentable subject matter to foster innovation amidst rapid technological advancements.
The essence of innovation lies in recognizing the human elements and nurturing individual creativity for collective benefit.
Other Barks & Bites for Wednesday, November 27: OpenAI Rebukes Deleted Evidence Accusations; Netlist Awarded $118 Million in Patent Infringement Lawsuit with Samsung; Report Finds Music Copyright Business is in Boom Time
Counterfeit goods remain a significant concern, as demonstrated by the seizure of fake guitars.
The DOJ is pressing charges against Google for monopolistic practices in online advertising.
OpenAI is engaged in a legal dispute with The New York Times regarding copyright infringement.